Home About Us Writing a Scientific Article Author's Instruction Contact us



/  /    MRJMMS Home   /   /    About MRJMMS    /  /    Submit Manuscripts    /  /      Call For Articles      / /     Editorial Board     / /    Archive     / /    Author's Guide  /  /


July 2018 Vol. 6 No.7

Other viewing option

• Full text
•Reprint (PDF) (65 KB)

Search Pubmed for articles by:

Deka S
Sonowal A

Other links:
PubMed Citation
Related articles in PubMed



Merit Research Journal of Medicine and Medical Sciences (ISSN: 2354-323X) Vol. 6(7) pp. 228-230, July, 2018 

Copyright © 2018 Merit Research Journals

Original Research Article

Hypercholesterolemia Detection of Public Health Camp to Prevent Cardiovascular Risk – An Experience in Iraq


Saurav Deka1*, Siddhesh Sharma1, Nitin Shelar2, Onkar Kulkarni2 and Abhijit Sonowal2


1Department of Medical and Clinical Research, Ajanta Pharmaceutical, Mumbai, India
2Global Marketing and Strategy Research, Ajanta Pharmaceutical, Mumbai, India

*Corresponding Author Email: hisaurav2000@yahoo.co.in
Mobile: +917600526455

Accepted July 02, 2018




Hypercholesterolemia is a major risk factors for the cardiovascular disease leading to morbidity and mortality. In last 30 years, Middle East has seen dramatic and significant changes in terms of economic development and their diet and life style, which leads to disarrangements in lipid profile. Lipid profile consists of group of biochemical tests (total cholesterol, triglycerides, high density lipoprotein and low density lipoprotein) often used in predicting and treating lipid related disorders specially atherosclerosis. Due to lack of awareness in people, high cholesterol becomes a major risk factor for the cardiovascular death. Public awareness is one of the successful tools to prevent such premature death. Total 20 cholesterol camps held in different hospitals and doctor’s clinics which includes12 in Baghdad, 3 in Najaf, and 2 in Erbil, Karbala and Hilaa and 1 in Diwania. Volunteers included both patients and their attendants present in the hospital premises for different reasons. Total 577 individual participated in cholesterol detection camps. Out of which 424 males and 153 females. 12% volunteers had total cholesterol level under 149 mg/dl, 24% had in between 150 and 179 mg/dl, 31% volunteers had in between 180 and 199 mg/dl, 25% volunteers had in between 200 and 249 mg/dl and 8% had above 250 mg /dl. So, out of total 577 patients, 33% patient had cholesterol level more than 200 mg/dl. 5% prescription of atorvastatin (ATORFIT) prescribed by Physician where cholesterol level in between 180 to 199. 8% prescription of atorvastatin (ATORFIT) prescribed by Physician where cholesterol level in between 200 to 249. 8% prescription of atorvastatin (ATORFIT) prescribed by Physician where cholesterol level above 250mg/dl.

Keywords: Hypercholesterolemia, cardiovascular disease, Morbidity, Mortality






Merit Research Journals© 2018 || Advertisement | Privacy policy.